After moderating a lengthy session on blood products at the 2015 Military Health System Research Symposium in Fort Lauderdale, Florida, Aug. 18, Dr. Heather Pidcoke summed up two hours of dense ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
East Hills, NY (October 22, 2007) -- Pall Corporation (NYSE: PLL) launches the new AcrodoseTM PLus System to ensure patients receive the safest possible platelet transfusion -- no matter what type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results